Pancreatic adenocarcinoma: Clinical practice guidelines in oncology

Margaret A. Tempero, J. Pablo Arnoletti, Stephen Behrman, Edgar Ben-Josef, Al B. Benson, Jordan D. Berlin, John L. Cameron, Ephraim S. Casper, Steven J. Cohen, Michelle Duff, Joshua D.I. Ellenhorn, William G. Hawkins, John P. Hoffman, Boris W. Kuvshinoff, Mokenge P. Malafa, Peter Muscarella, Eric K. Nakakura, Aaron R. Sasson, Sarah P. Thayer, Douglas S. TylerRobert S. Warren, Samuel Whiting, Christopher Willett, Robert A. Wolff

Research output: Contribution to journalReview articlepeer-review

157 Scopus citations


Overall, in view of the relatively high likelihood of a poor outcome for patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.

Original languageEnglish
Pages (from-to)972-973+991-1016
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number9
StatePublished - Sep 2010


  • Adenocarcinoma
  • Ductal carcinoma
  • Endoscopic retrograde cholangiopancreatography
  • Gemcitabine
  • NCCN clinical practice guidelines
  • NCCN guidelines
  • Pancreas
  • Ultrasonography


Dive into the research topics of 'Pancreatic adenocarcinoma: Clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this